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Objective: This study reviews the 223 consecutive mitral valve operations for
ischemic mitral insufficiency performed at New York University Medical Center
between January 1976 and January 1996. The results for mitral valve reconstruction
are compared with those for prosthetic mitral valve replacement.
Methods: From January 1976 to January 1996, 223 patients with ischemic mitral
insufficiency underwent mitral valve reconstruction (n = 152) or prosthetic mitral valve
replacement (n = 71). Coronary artery bypass grafting was performed in 89% of cases
of mitral reconstruction and 80% of cases of prosthetic replacement. In the group under-
going reconstruction, 77% had valvuloplasty with a ring annuloplasty and 23% had
valvuloplasty with suture annuloplasty. In the group undergoing prosthetic replacement,
82% of patients received bioprostheses and 18% received mechanical prostheses.
Results: Follow-up was 93% complete (median 14.6 mo, range 0-219 mo). Thirty-
day mortality was 10% for mitral reconstruction and 20% for prosthetic replacement.
The short-term mortality was higher among patients in New York Heart Association
functional class IV than among those in classes I to III (odds ratio 5.75, confidence
interval 1.25-26.5) and was reduced among patients with angina relative to those with-
out angina (odds ratio 0.26, confidence interval 0.05-1.2). The 30-day death or com-
plication rate was similarly elevated among patients in functional class IV (odds ratio
5.53; confidence interval 1.23-25.04). Patients with mitral valve reconstruction had
lower short-term complication or death rates than did patients with prosthetic valve
replacement (odds ratio 0.43, confidence interval 0.20-0.90). Eighty-two percent of
patients with mitral valve reconstruction had no insufficiency or only trace insuffi-
ciency during the long-term follow-up period. Five-year complication-free survivals
were 64% (confidence interval 54%-74%) for patients undergoing mitral valve recon-
struction and 47% (confidence interval 33%-60%) for patients undergoing prosthetic
valve replacement. Results of a series of statistical analyses suggest that outcome was
linked primarily to preoperative New York Heart Association functional class.
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Mitral insufficiency caused by coronaryischemia has various clinical presenta-tions, ranging from cardiogenic shockrelated to acute papillary muscle rup-ture to chronic congestive heart failurerelated to ventricular dysfunction with
annular dilation. Reported perioperative mortality for mitral
reconstruction in these patients ranges widely, from 9%1 to
18%,2 although the variety of patient subtypes makes it dif-
ficult to analyze the impact of mitral valve reconstructive
techniques in reports on small patient groups. Although
mitral reconstruction demonstrably provides better preserva-
tion of ventricular function3 than does mitral replacement
without chordae-sparing procedures and produces superior
freedom from valve-related complications4 in patients with
degenerative mitral insufficiency, similar advantages have
not yet been definitely demonstrated for the subset of
patients with ischemic mitral insufficiency. Kay and col-
leagues5 demonstrated good results with mitral repair for
patients with ischemic mitral insufficiency, but no analyses
were performed to examine the impact of confounding vari-
ables. A study by Cohn and associates6 reported that mitral
reconstruction in patients with ischemic mitral insufficiency
was associated with a 5-year mortality 5 times higher than
that seen after replacement. Confounding variables, such as
acuity of presentation, degree of global ventricular dysfunc-
tion, and the specific pathophysiologic characteristics of the
ischemic mitral insufficiency, certainly influenced these out-
comes. A large experience with long follow-up is required to
resolve these issues and to provide a valid comparison
between mitral valve reconstruction and valve replacement
for patients with ischemic mitral insufficiency. This study
reviews New York University Medical Center’s 19-year
experience with operations for ischemic mitral insufficiency.
Methods
Variable Definitions
Ischemic mitral insufficiency was considered to be the presence of
severe mitral incompetence (according to either echocardiographic
or angiographic criteria) arising from an ischemic process confirmed
by the intra-operative pathologic evaluation of the valve. Patients
with other causes for the mitral insufficiency (degenerative,
rheumatic, infective, or congenital) were excluded from this analy-
sis. Mitral insufficiency was considered acute if the onset of symp-
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toms was less than 1 month before the operation or was associated
with an acute myocardial infarction during the same hospitalization.
A modification of the pathophysiologic classifications proposed
by Rankin and colleagues,7 Carpentier,8 and Cohn and associates6
was used. The mitral insufficiency cases were classified into three
largely exclusive categories. Annular dilation was characterized as
intact leaflets, chordae, and papillary muscles in association with a
dilated anulus (type 1). Structural mitral insufficiency was charac-
terized by the presence of ruptured or elongated papillary muscles
(type 2). Ventricular-papillary dysfunction consisted of ischemic or
infarcted nonruptured papillary muscles in association with normal
chordae and intact anulus and leaflets (type 3).
Patient Population
From January 1976 through January 1996, a total of 223 consecu-
tive patients at our institution underwent isolated mitral valve
surgery for severe mitral insufficiency of ischemic origin. Mitral
insufficiency was measured by either preoperative ventriculogra-
phy or echocardiography; in the latter half of this series intraoper-
ative transesophageal echocardiography was routinely used. The
mitral operations included 152 reconstructions (77% Carpentier
technique4 with ring annuloplasty and 23% suture annuloplasty)
and 71 mitral valve replacements (82% with bioprostheses and
18% with mechanical prostheses). Moderate systemic hypother-
mia and cold blood cardioplegia were used throughout the series,
with retrograde cardioplegic delivery used extensively in the last
decade. The patients undergoing mitral replacement had preserva-
tion of the posterior leaflet whenever possible. Mitral replacement
was preferred for patients with significant disruption or necrosis of
the papillary muscle and with ventricular-papillary muscle dys-
function. Annular dilation was preferentially treated with mitral
reconstruction.
The mean age for all the patients in the study was 67.9 ± 8.8
years, and 86% of the patients underwent concomitant coronary
artery bypass grafting. Those patients who did not undergo con-
comitant coronary artery bypass grafting typically had either acute
papillary muscle rupture in association with a completed trans-
mural infarction or chronic mitral insufficiency with coronary dis-
ease that could not be ameliorated by coronary artery bypass
grafting. Indices of preoperative risk included preoperative use of
an intra-aortic balloon pump in 7% of the cases, preoperative intu-
bation in 13%, and cardiogenic shock in 5%. Ventricular function
was impaired in most patients (54%).
After the operation all patients received coumadin for the first
3 months if tolerated. After that, patients with a mechanical valve,
chronic atrial fibrillation, or history of thromboembolic events
continued to receive coumadin indefinitely.
Conclusions: Initial mortalities were similar among patients undergoing prosthetic
replacement and valve reconstruction. Poor outcome was primarily related to preex-
isting comorbidities. Patients undergoing valve reconstruction had fewer valve-
related complications. Valve reconstruction resulted in excellent durability and
freedom from complications. These findings suggest that mitral valve reconstruction
should be considered for appropriate patients with ischemic mitral insufficiency.
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Operative information and patient demographic characteristics
for mitral valve patients are routinely collected at our institution
and are maintained in a database. The standard terminology for
reporting valvular surgery outcomes, such as hospital mortality,
was used throughout.9 Patients were followed up for complications
and deaths from all causes. Deaths from all causes are reported
here, but late death (death from any cause of a patient who sur-
vived ≥30 days after surgery) was also examined. Late cardiac
death (including valve-related deaths, sudden unexplained deaths
and deaths due to congestive heart failure, acute myocardial infarc-
tion, and documented fatal arrhythmias) was the cause of all but
one of these late deaths. All patients who underwent mitral valve
reconstruction were requested to undergo echocardiographic
assessment of the mitral valve at 6 months and at 1 year after the
operation and then once a year after the first year. The results of the
most recent echocardiographic assessment were obtained at fol-
low-up contact. For the follow-up study, clinical research nurses
contacted the patients, their families, or their physicians once each
year. Follow-up was obtained in 97% of cases; searches made with
the social security numbers of those patients who were unavailable
for follow-up suggested that they were still alive, although they
could not be contacted. A total of 550 patient-years of follow-up
was reviewed in this report (mean 30.8 months, median 14.6
months, range 0-219 months). Figure 1 shows the distribution of
follow-up times according to type of surgery.
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Statistical Methods
The case series described is observational, and it is recognized that
the choice of surgical procedure may be biased by physician pref-
erence and patient characteristics. To examine these issues, multi-
ple exploratory analyses were undertaken. The strategy is
described here.
Characteristics were compared at baseline (time of surgery) for
patients who underwent valve replacement and valve repair proce-
dures. To screen for baseline differences between the two groups
of patients, distributions of characteristics at surgery were com-
pared with 2-sided t tests for the continuous variables such as age
and with χ2 tests or Fisher exact tests for the categorical variables.
Because the P values were used only as a screening tool, no adjust-
ments for multiplicity were made.
Differences between the operative groups at the time of surgery
were then examined with methods of linear discriminant analysis
and multiple logistic regression. Variables selected for inclusion in
these analyses included the variables judged from the univariate
analyses to be potentially different between the two groups and
also included other variables that may play an important role in the
choice of procedure to be performed. All subjects with complete
data on all candidate variables were included in the models. Model
diagnostics and goodness of fit tests (Hosmer-Lemeshow C statis-
tics for the logistic models and The Hotelling T square for the lin-
ear discriminant models) were performed.
Figure 1. Follow-up after surgery according to type of surgery.
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Thirty-day mortalities in the repair and replacement groups
were also compared with multiple logistic regression models.
Models were selected with procedures similar to those described
previously to compare the two groups of patients at the time of
surgery.
Time-to-failure curves were compared with log-rank tests for
(1) total mortality (death) and (2) first complication or death across
the entire follow-up period. Cox proportional hazard models were
also developed to compare the patients in the two groups with
adjustments for variables that were (1) selected from the analyses
of the baseline characteristics as sources of possible differences
between the repair and replacement groups, and (2) considered a
priori to be important in the choice of surgery or prognosis. Model
diagnostics and likelihood ratio tests for goodness of fit were per-
formed. Hazard ratios and 95% confidence intervals (CIs) were
estimated from these models. Time-to-failure models were also
developed for the repair and replacement groups separately to
explore the effects of patient selection on the results of the com-
parisons between the two groups of patients.
To assess the potential impact on model development of the use
of cases with complete data, Kaplan-Meier survival curves were
compared for patients with and without complete data in the repair
and replacement groups separately.
Supplementary analyses with propensity score methods10 were
also applied to aid in the understanding of the impact of covariates
on outcome in these two selected groups of patients. All analyses
were carried out with SAS V.8.0 (SAS Institute, Inc, Cary, NC) and
S Plus 2000 software packages.
Results
Baseline Characteristics and Outcomes
Baseline characteristics. Two hundred twenty-three con-
secutive patients underwent surgery with either mitral valve
repair (n = 152) or replacement (n = 71) at New York
University Medical Center between 1976 and 1996. Table
1A provides a summary of the characteristics of these
patients at the time of operation. The average age of these
patients was 68 years. Although the groups were comparable
in many respects, the proportion of the patients in New York
Heart Association (NYHA) functional class IV was greater
among the patients undergoing replacement (79%) than
among those undergoing repair (59%). Ninety-two percent
of patients in the repair group had angina, and 96% of the
patients in the replacement group had congestive heart fail-
ure. The distributions of time of surgery (year) were also
markedly different in the two groups of patients (Figure 1).
In fact, few repairs were conducted in patients with ischemic
mitral insufficiency before 1988. We therefore examined this
cohort effect (before 1988 vs 1988 or later) by separately
performing all the multivariable analyses reported here on
patients operated on in the latter half of our series; Table 1B
provides a comparison of the two groups after 1988. Table 2
provides a summary of the mortality and complication out-
comes according to type that are included in the subsequent
analyses of mortality and complication-free survival.
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The choice of operative procedure depended on the char-
acteristics of the patient at presentation. The distributions of
pathophysiologic subtypes according to type of surgery are
summarized in Tables 1A and 1B. Note that 17% of the
patients in the repair group had acute regurgitation, com-
pared with 29% of those in the replacement group, and 67%
of the patients in the repair group had isolated annular dila-
tion, compared with only 34% in the replacement group.
Linear discriminant analysis and multiple logistic regres-
sion analyses were carried out to explore the differences
between the two operative groups. The following variables
were included in the various exploratory analyses: surgery
before or after 1988, acuity of mitral insufficiency, annular
dilation, structural failure such as ruptured papillary muscle,
ventricular papillary muscle dysfunction, congestive heart
failure, NYHA functional class, gender, concomitant coro-
nary artery bypass grafting, previous cardiac surgery, emer-
gency operation, angina, diabetes, and age. The most
important variable found from these models was the year of
surgery (1988 or later vs before 1988). Tables 3A and 3B
summarize the results of the models resulting from each of
these two approaches. Only NYHA functional class and the
presence of annular dilation were significant in the multi-
variable analyses. Furthermore, in all the exploratory mod-
els the predicted classification was poor (<20% correct).
Goodness of fit was assessed with the Hosmer-Lemeshow C
statistics for the logistic models and the Hotelling T square
for the linear discriminant models.
Logistic regression models that included all covariates
were also used to attempt to develop propensity scores for
repair versus replacement. Forty percent of the patients in
the replacement group were in the lowest quintile of
propensity score, as opposed to only 4% of the patients in
the repair group, and 10% of the patients in the replacement
group were in the highest quintile of propensity score, as
opposed to 68% of repair patients. Quintile II consisted
entirely of patients treated before 1988. The propensity
score models did not provide an adequate fit to the data
within quintiles of risk (Hosmer-Lemeshow C statistic, χ2
(8 df) = 18.33, P = .0189). When the choice of operative
procedure is confounded with respect to disease character-
istics, it is not unexpected that no balance can be achieved
through the use of propensity scores.10-12 Propensity scores
were therefore not used to carry out adjustments in the sub-
sequent analyses reported here.
Table 4 illustrates the nature of the confounding among
NYHA functional classification and the presence or absence of
angina and choice of repair or replacement procedure. Thirty-
six percent of the patients in the repair group were in NYHA
functional classes I through III with angina, compared with
18% of those in the replacement group. Only 2% of the
patients in the repair group were in functional class IV without
angina, compared with 20% of those in the replacement group.
Grossi et al Surgery for Acquired Cardiovascular Disease
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TABLE 1A. Comparison of patient characteristics (for all patients)
Mitral repair (N = 152, 68%) Mitral replacement (N = 71, 32%)
Total cases (N = 223) No. % No. % P value*
Patient characteristics
Age 222 151† 68 71‡ 32 .92§
Missing 1
Gender 222 151 71 .53
Male 96 64 42 59
Female 55 36 29 41
Missing 1
Preoperative NYHA functional class 222 152 70 .02¶
I 1 0.7 0
II 7 4.6 2 2.9
III 55 36.2 13 18.6
IV 89 58.6 55 78.6
Missing 1
Concomitant coronary artery bypass grafting 223 152 71 .09
Yes 135 89 57 80
No 17 11 14 20
Previous cardiac surgery 223 152 71 .97
Yes 19 12 9 13
No 133 88 62 87
Emergency operation 223 152 71 .72
Yes 42 28 18 25
No 110 72 53 75
Preoperative angina 209 152 57 .001
Yes 140 92 43 75
No 12 8 14 25
Missing 14
Diabetes 223 152 71 .91
Yes 46 30 22 31
No 106 70 49 69
Preoperative ejection fraction 127 110 17 .94¶
≤20 38 35 6 35
>20-30 22 20 4 24
>30 50 45 7 41
Missing 42 54
Congestive heart failure 221 150 71 .05
Yes 131 87 68 96
No 19 13 3 4
Missing 2
Pathophysiologic subtypes
Mitral regurgitation 213 150 63 .05
Acute 25 17 18 29
Chronic 125 83 45 71
Missing 2 8
Pathophysiology 223 152 71 <.0001
Isolated annular 102 67 24 34
Structural 34 22 24 34
Papillary muscle dysfunction 16 11 23 32
Operative characteristics
Aortic occlusion time 182 134** 74 48†† 26 <.0001§
Missing 18 23
Bypass time 183 134‡‡ 73 49§§ 27 .0013§
Missing 18 22
Type of operation 221 150 71 .33¶
Elective 95 63 44 62
Emergency 36 24 18 25
Reoperation 13 9 9 13
Emergency reoperation 6 4 0 0
Missing 2
*All tests are 2-sided. Missing values were not included in the calculations.
†Mean, 67.98 years.
‡Mean, 67.85 years.
§By t test.
 By χ2 test.
¶By Fisher exact test.
**Mean 59.8 minutes.
††Mean 104.77 minutes.
‡‡Mean 144 minutes.
§§Mean 177 minutes.
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TABLE 1B. Comparison of patient characteristics after 1988
Mitral repair Mitral replacement
(N = 127, 79.38%) (N = 33, 20.62%)
Total cases (N = 160) No. % No. % P value*
Patient characteristics
Age 159 126† 79 33‡ 21 .89§
Missing 1
Gender 159 126 33 .53
Male 80 64 19 58
Female 46 36 14 42
Missing 1
Preoperative NYHA functional class 159 127 32 .04¶
I 0 0
II 5 4 1 3
III 44 35 4 13
IV 78 61 27 84
Missing 1
Concomitant coronary artery bypass grafting 160 127 33 .13
Yes 110 87 25 76
No 17 13 8 24
Previous cardiac surgery 160 127 33 27 .07
Yes 18 14 9
No 109 86 24 73
Emergency operation 160 127 33 .70
Yes 39 31 9 27
No 88 69 24 73
Preoperative angina 149 127 22 .04¶
Yes 121 95 18 82
No 6 5 4 18
Missing 11
Diabetes 160 127 33 .05
Yes 42 33 13 39
No 85 67 20 61
Preoperative ejection fraction 122 106 16 .88
≤20 38 36 5 31
>20-30 21 20 4 25
>30 47 44 7 44
Missing 21 17
Congestive heart failure 159 126 33 .07¶
Yes 113 90 33 100
No 13 10 0 0
Missing 1
Pathophysiologic subtypes
Mitral regurgitation 158 125 33 .05
Acute 22 18 11 33
Chronic 103 82 22 67
Missing 2
Pathophysiology 160 127 33 <.001
Isolated annular dilation 90 71 11 33
Structural 26 20 14 43
Papillary muscle dysfunction 11 9 8 24
Operative characteristics
Aortic occlusion time 149 118** 79 31†† 21 <.001§
Missing 9 2
Bypass time 150 118‡‡ 78.8 32§§ 21.3 .015§
missing 9 1
Type of operation 158 125 33 .05¶
Elective 74 59 15 45
Emergency 33 26 9 27
Reoperation 12 10 9 27
Emergency reoperation 6 5 0 0
Missing 2
*All tests are 2-sided. Missing values were not included in the calculations.
†Mean 68.75 years.
‡Mean 68.94 years.
**Mean 54.39 minutes.
††Mean 115.19 minutes.
‡‡Mean 141.1 minutes.
§§Mean 183.66 minutes.
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Outcome: 30-day mortality and complication-free
survival. Thirty-day mortality and complications or death
within 30 days were examined with logistic regression
analysis (Tables 5A and 5B). The results, shown in Table 5A,
suggest that the odds of death within 30 days after surgery
for all patients and for patients operated on in 1988 or later
were markedly elevated for patients in NYHA functional
class IV relative to patients in classes I through III (9.6 times
greater and 5.8 times greater, respectively). Results were
similar for death or complication within 30 days of surgery.
No other variable, including type of operative procedure,
contributed significantly to the prediction of the odds of
death within 30 days.
Because of the high degree of confounding of type of
surgery with the presence of angina and NYHA functional
class at baseline, logistic models were also fitted excluding
angina and NYHA functional class. Table 5B provides the
results of these analyses, which suggest that the odds of death
within 30 days after surgery or complication or death within
30 days after surgery were significantly lower for patients
with repair than for patients with replacement. This result
supports the observation that the selection of patients for type
of surgery is confounded with NYHA functional class and the
presence of angina, and the lowered risk for patients in the
repair group may have been due to the selection criteria for
the surgery rather than to the surgical procedure.
Outcome: Survival and complication-free survival.
Survival for all patients in the cohort is shown in Figure 2,
A; survival for patients operated on in 1988 or later is shown
in Figure 2, B. The risk of death for the repair group relative
to the replacement group was 0.75 (95% CI 0.463-1.202)
The Journal of Thoracic and Cardiovascular Surgery • Volume 122, Number 6   1113
for all patients and was 0.66 (95% CI 0.338-1.302) for
patients entered in 1988 or later. Appendix Tables 1A and
2A provide survival rates for 5 years from surgery for all
patients and for patients entered in 1988 or later.
Figure 3, A and B, provides similar curves for complica-
tion-free survival. The risk of complication or death for repair
relative to replacement was 0.63 (95% CI 0.405-0.980) for all
patients and 0.50 (95% CI 0.267- 0.952) for patients operated
on in 1988 or later. Appendix Tables 1B and 2B provide the
complication-free survival rates for 5 years after surgery. For
the group of patients with surgery in 1988 or later who could
have received either operation, there was a possible advantage
to repair rather than replacement according to the unadjusted
hazard ratios. Adjustments were therefore explored.
Outcome: Survival and complication-free survival for
patients surviving complication free for 30 days. Figure 4,
A and B, provides survival curves for all patients and for all
patients operated on in 1988 or later who survived free of
complications for 30 days after surgery. Figure 5, A and B,
provides the complication-free survival for the same groups
of patients. The curves for survival and for complication-
free survival conditional on complication-free survival for
30 days after surgery were similar for both types of surgery
in the early years after surgery. The hazard ratios and 95%
CI for survival and complication-free survival for patients
who survived free of complications for 30 days or longer are
provided in Table 6. Although the hazard ratios for repair
versus replacement were consistently below unity, the 95%
CIs were wide.
Outcome: Postdischarge survival and complication-free
survival. We also examined the outcomes of the 150 patients
TABLE 2. Patient outcomes by type of surgery and time of surgery
Mitral repair Mitral replacement
Total During and after 1988 Total During and after 1988
All patients
(N = 152) (N = 127) (N = 71) (N = 33)
(N = 223) No. % No. % No. % No. %
Complications
Thromboembolic 9 3 2 1 0.8 6 8 0 0
Anticoagulation 5 1 0.7 0 0 4 6 2 6
Endocarditis 2 0 0 0 0 2 3 1 3
Death
Any death 72 41 27 30 24 31 44 13 39
Within 30 d 29 15 10 12 10 14 20 18 24
After 30 d 43 26 17 18 14 17 24 5 15
In hospital 38 23 15 18 14 15 21 9 27
In hospital within 30 d 29 15 10 12 10 14 20 8 15
Complications or death
Any complication 82 45 30 31 24 37 52 15 45
Within 30 d 31 15 10 12 10 16 22 9 27
After 30 d 51 30 20 19 14 21 30 6 18
G
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who were discharged from the hospital. We defined survival
time as the interval from the date of the discharge to the date of
death. The risk of death for repair relative to replacement was
0.98 (95% CI 0.36-2.66), and the risk of complication or death
was 0.95 (95% CI 0.38-2.36). For patients operated on in 1988
or later, the risk of death was 0.87, 95% CI (0.27, 2.74) and the
risk of complication or death is 0.71 with 95% CI (0.25, 2.04).
Thus for those patients who were discharged from the hospital
the outcomes were similar regardless of type of surgery.
The risk of death in the hospital for repair relative to
replacement was 0.98 (95% CI 0.5-1.97), and the risk of
complication or death was 0.81 (95% CI 0.43-1.56). For
Surgery for Acquired Cardiovascular Disease Grossi et al
Figure 2. Survival according to type of operation. A, All patients; B, patients operated on in 1988 or later. Filled dia-
monds represent replacement; open circles represent repair.
A
B
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patients entered in 1988 or later, the risk of death and the
risk of complication or death were 0.72 (95% CI 0.32-1.6)
and 0.63 (95% CI 0.29-1.35).
Outcomes according to characteristics at time of surgery
(patients entered in 1988 or later). Table 7 shows the hazard
ratios for death and for complication or death for patients who
received mitral repairs relative to those who received valve
replacements in 1988 or later within subgroups defined by
levels of baseline variables. Although the numbers of patients
in each subgroup were small, the results suggest that within
most of these subgroups patients with repair had a lower risk
of death or complication or death than did patients with
replacement (although most of the CIs on the hazard ratios
included unity). Patients older than 70 years had markedly
lower risks with repair, as did patients without concomitant
coronary artery bypass grafting, patients with emergency
surgery, and patients with isolated annular dilation.
Cox proportional hazards models were also used to
adjust for covariates in the comparison of survivals between
repair and replacement groups operated on in 1988 or later.
Because of the confounding of baseline covariates with
patient selection, Cox models were also developed without
angina and NYHA functional class, the variables that
appeared to be associated with patient selection groups sep-
arately. Variables included were those discerned from the
baseline comparisons and those discovered in the earlier
analyses to be confounded with type of surgery.
Tables 8A and 8B present the results of the model for the
comparison of repair and replacement groups. In Table 8A
all variables are included for model selection in addition to
the type of surgery. The variables included in the final mod-
els are provided, along with the associated adjusted hazard
ratios and 95% CIs and the test of model fit. Patients in
NYHA functional class IV had a markedly increased
adjusted risk or complication in all the patient subsets.
TABLE 3A. Multivariate comparison of valve replacement and valve repair groups: Multiple logistic regression method
(response variable, type of valve procedure)
Repair Replacement Goodness of fit
group group Model, variables included Odds ratio 95% CI (Hosmer-Lemeshow test)
All patients
152 70 NYHA functional class (IV vs ≤III) 0.26 0.12-0.57 χ26 = 0.67, P = .637)
After 1988 (vs earlier) 6.27 3.08-12.73
Isolated annular dilation (vs not) 3.25 1.81-6.84
Patients entered 1988 or later
127 22 Preoperative angina (vs none) 4.96 1.13-21.79 χ22 = 0.67, P = .720
Isolated annular dilation (vs not) 5.41 1.99-14.72
Variables included: NYHA functional class, type of valve procedure, preoperative angina, previous cardiac surgery, type of mitral regurgitation, conges-
tive heart failure, concomitant coronary artery bypass grafting, diabetes, gender, age, anulus, entry after 1988, and the need for reoperation.
TABLE 3B. Multivariate comparison of valve replacement and valve repair groups: Linear discriminant analysis method2
(dependent variable, type of valve procedure)
Variables Estimated coefficient 95% CI Hotelling T square
All patients
Isolated annular dilation (vs not) –0.3 –0.53 to –0.08 F(12,183) = 5.64, P < .001)
After 1988 (vs earlier) –0.4 –0.6 to –0.2
Patients entered 1988 or later
Isolated annular dilation (vs not) 0.37 0.043 to 0.697 F(11,132) = 2.9, P = .002)
Variables included: NYHA functional class, type of valve procedure, preoperative angina, structural failure, previous cardiac surgery, type of mitral regurgi-
tation, congestive heart failure, concomitant coronary artery bypass grafting, diabetes, gender, age, isolated annular dilation, and the need for reoperation.
TABLE 4. Distribution of patients with repair and replace-
ment according to NYHA functional class and presence of
angina
Mitral
Mitral repair replacement
NYHA functional class Angina No. % No. %
I, II, or III No 9 5.9 3 5.53
I, II, or III Yes 54 35. 5 10 17.9
IV No 3 1.97 11 19.6
IV Yes 86 56.58 32 57.1
TOTAL 152 56
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contributed to modification of the risks, although the partic-
ular characteristics varied with the patient subset. In no
instance did the type of surgery emerge as an additional
independent variable that contributed to outcome.
NYHA functional class and angina, two major con-
founding variables discovered in the comparison of the two
groups at time of surgery, were eliminated from the model
selection process. The results of this process are provided in
Table 8B. In these models patients in the repair group had
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Figure 3. Complication-free survival according to type of operation. A, All patients; B, patients operated on in 1988 or later.
Filled diamonds represent replacement; open circles represent repair.
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45% to 61% the adjusted risk of death of those in the
replacement group and 55% to 61% the adjusted risk of
complication or death in the presence of the covariates
included. These results confirm the selection process asso-
ciated with the choice of surgery for these patients.
Because of the patient selection inherent in the choice of
surgical procedure and the confounding of baseline character-
istics at time of surgery with the choice of procedure, we also
developed Cox models for each of the two surgical cohorts sep-
arately. Table 9 provides the results of the Cox models for each
of the groups. Among all patients in the repair group the rela-
tive risk of death or any event was 3 times greater for patients
in NYHA functional class IV than for those in classes I through
III. For patients with replacement, those with mitral structural
failure had a third the risk of complication or death of those
without structural failure. For patients operated on in the latter
half of our series, the risks for patients in NYHA functional
class IV were even greater; risks were also increased for
patients with emergency surgery or previous cardiac surgery.
To assess the impact of missing data on the conclusions
of this study, Kaplan-Meier survival curves were compared
in each of the two treatment groups for patients (1988 or
later) with complete data included in the final models and
patients with incomplete data who were not included in the
final models. The respective hazard rates for mortality for
patients with complete data relative to patients with incom-
plete data were 0.90 (95% CI 0.38-2.12) for repair and 1.75
(95% CI 0.50-6.12) for replacement.
TABLE 5A. Odds ratios for death within 30 postoperative days and for complications or death within 30 postoperative
days: Multiple logistic regression
Patient subsets Model variables included Odds ratio 95% CI Hosmer-Lemeshow test
30-d mortality
All patients NYHA functional class (IV vs ≤III) 9.58 2.2-41.3 χ22 = 0.62
Valve procedure (repair vs replacement) 0.65 0.3-1.45 P = .73
Patients entered 1988 or later Preoperative angina (yes vs no) 0.26 0.05-1.2 χ22 = 0.65
NYHA functional class (IV vs ≤III) 5.75 1.25-26.5 P = .42
Complications or death within 30 d
All patients NYHA functional class (IV vs ≤III) 9.36 2.2-40.5 χ22 = 0.42
Valve procedure (repair vs replacement) 0.54 0.25-1.19 P = .81
Patients entered 1988 or later Valve procedure (repair vs replacement) 0.43 0.2-0.9 χ22 = 1.38
NYHA functional class (IV vs ≤III) 5.53 1.23-25.04 P = 0.81
TABLE 5B. Odds ratios for death within 30 postoperative days and for complications or death within 30 postoperative
days: Multiple logistic regression excluding NYHA functional class and angina from covariables
Patient subsets Model variables included Odds ratio 95% CI Hosmer-Lemeshow test
30-d mortality
All patients Isolated annular dilation (yes vs no) 1.99 0.85-4.67 χ22 = 4.57
Valve procedure (repair vs replacement) 0.4 0.18-0.93 P = .1
Patients entered 1988 or later Valve procedure (repair vs replacement 0.34 0.12-0.96 χ22 = 3.82
Isolated annular dilation (yes vs no) 0.15 0.52-4.1 P = .15
Complications or death within 30 d
All patients Diabetes (yes vs no) 1.87 0.87-4.0 χ22 = 0.06
Valve procedure (repair vs replacement) 0.43 0.2-0.9 P = .97
Patients entered 1988 or later Valve procedure (repair vs replacement) 0.34 0.13-0.89 χ22 = 0.137
Diabetes (yes vs no) 2.3 0.93-5.76 P = .99
TABLE 6. Hazard ratios for survival and for complication-
free survival for patients who survived free of complica-
tions for at least 30 days
Event Hazard ratio 95% CI
All patients
Survival 0.88 0.47-1.65
Complication-free survival 0.74 0.42-1.32
Patients entered in 1988 or later
Survival 0.73 0.27-2.02
Complication-free survival 0.62 0.25-1.62
Hazard ratio is for repair versus replacement.
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reconstruction. In our series of patients who had repair
operations performed in 1988 or later and survived for at
least 30 days, the unadjusted risk of death after 30 days was
0.29 (95% CI 0.1-0.83) for repair with a ring annuloplasty
relative to simple suture repair, and the unadjusted risk of
complication or death was 0.32 (95% CI 0.11-0.91) for ring
annuloplasty repair relative to suture annuloplasty repair.
Appendix Table 3 provides the Cox models and adjusted
hazard ratios.
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Figure 4. Survival according to type of operation for patients with freedom from complications for 30 days. A, All
patients; B, patients operated on in 1988 or later. Filled diamonds represent replacement; open circles represent
repair.
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Discussion
The central questions pertinent to the treatment of ischemic
mitral insufficiency by reconstructive techniques include
effectiveness, appropriateness, and long-term benefits.
Although none of these questions can be answered directly
from the data in this 2-decade nonrandomized experience,
several conclusions can be drawn.
Is Mitral Reconstruction an Effective Treatment
Option?
Although the different exploratory statistical approaches do
not permit us to conclude that there is an independent impact
(positive or negative) of operative procedure, the immediate
postoperative outcomes were most predicated on the covari-
ates of NYHA functional class, emergency surgery, and pre-
vious cardiac surgery. In almost every patient baseline
subgroup the comparison of reconstruction with replace-
ment demonstrated a hazard ratio of less than unity for the
risk of death or complication within 30 days. This result
suggests evidence of improved immediate outcomes among
patients selected for mitral valve reconstruction. In fact, the
1-year survival for patients who underwent reconstruction
in 1988 or later was 78%, and the relative risk of death dur-
ing the follow-up period for patients who were in NYHA
functional classes I through III was a third that of patients in
NYHA functional class IV.
TABLE 7. Comparison of outcomes for repair versus replacement: The relative hazard ratios for death and for complica-
tions or death by patient characteristics
Death Complication or death
Baseline variables Hazard ratio 95% CI Hazard ratio 95% CI
NYHA functional class
I, II, or III 0.264 0.050-1.386 0.187 0.034-1.021
IV 0.957 0.444-2.063 0.753 0.370-1.532
Preoperative angina
Yes 0.151 0.015-1.467 0.151 0.015-1.467
No 0.965 0.367-2.540 0.665 0.274-1.612
Congestive heart failure
Yes NA NA NA NA
No 0.717 0.364-1.411 0.545 0.287-1.033
Type of mitral regurgitation
Acute 0.495 0.238-1.026 0.453 0.224-0.913
Chronic 0.543 0.076-3.872 0.297 0.049-1.789
Emergency
No 0.394 0.179-0.870 0.343 0.159-0.741
Yes 1.82 0.409-8.102 1.003 0.285-3.527
Diabetes
Yes 0.538 0.208-1.393 0.538 0.208-1.393
No 0.773 0.288-2.073 0.51 0.213-1.218
Structural failure
No 0.574 0.256-1.288 0.41 0.190-0.882
Yes 0.705 0.189-2.631 0.557 0.161-1.927
Isolated annular dilation
Yes 0.779 0.261-2.322 0.499 0.180-1.379
No 0.32 0.129-0.794 0.336 0.136-0.830
Previous cardiac surgery
No 0.638 0.281-1.447 0.441 0.208-0.932
Yes 1.46 0.382-5.579 1.004 0.3-3.36
Coronary artery bypass grafting
No 0.166 0.03-0.915 0.166 0.03-0.915
Yes 0.94 0.246-2.078 0.647 0.314-1.334
Gender
Male 0.91 0.289-2.864 0.736 0.259-2.093
Female 0.492 0.214-1.132 0.422 0.189-0.94
Age
≤60 y 1.479 0.161-13.591 0.525 0.095-2.893
>60-70 y 0.957 0.262-3.501 0.75 0.238-2.364
>70 y 0.406 0.171-0.963 0.406 0.171-0.963
Hazard ratios are for the end point in the repair group versus the replacement group estimated from Cox proportional hazard models. For patients entered
in 1988 or later.
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For Which Patients Is Repair Appropriate?
Although the applicability of reconstruction is easily appreci-
ated in the subset of patients with chronic ischemia and annu-
lar dilation, it is noteworthy that 17% of the repairs in our
series were done in cases of acute ischemic mitral insuffi-
ciency. These cases are challenging to the surgeon because
evaluation of the damage to the subvalvular apparatus may be
difficult. Not only does structural damage (ruptured chordae
Surgery for Acquired Cardiovascular Disease Grossi et al
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Figure 5. Complication-free survival according to type of operation for patients with freedom from complications for
30 days. A, All patients; B, patients operated on in 1988 or later. Filled diamonds represent replacement; open circles
represent repair.
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TABLE 8A. Cox models for survival and for complication-free survival
Event Covariates Hazard ratio 95% CI
All patients
Complication-free survival NYHA functional class (IV vs ≤III) 2.78 1.59-4.85
Structural failure (yes vs no) 0.54 0.3-0.97
Survival NYHA functional class (IV vs ≤III) 2.85 1.58-5.13
Previous cardiac surgery (yes vs no) 2.15 1.15-4.03
Patients entered in 1988 or later
Complication-free survival NYHA functional class (IV vs ≤III) 4.4 1.8-10.8
Previous cardiac surgery (yes vs no) 2.7 1.3-5.9
Mitral regurgitation (acute vs chronic) 0.28 0.08-0.95
Preoperative angina (yes vs no) 0.36 0.14-0.98
Survival NYHA functional class (IV vs ≤III) 3.99 1.69-9.45
Previous cardiac surgery (yes vs no) 2.79 1.28-6.09
Mitral regurgitation (acute vs chronic) 0.15 0.03-0.66
Preoperative angina (yes vs no) 0.34 0.13-0.91
TABLE 8B. Cox models for survival and complication-free survival excluding NYHA functional class and preoperative
angina from covariables
Event Covariates Hazard ratio 95% CI
All patients
Complication-free survival Type of valve procedure (repair vs replacement) 0.55 0.35-0.87
Structural failure (yes vs no) 0.47 0.27-0.84
Diabetes (yes vs no) 1.77 1.22-2.87
Survival Type of valve procedure (repair vs replacement) 0.61 0.36-0.99
Structural failure (yes vs no) 9.31 1.28-67.63
Congestive heart failure (yes vs no) 0.44 0.24-0.82
Mitral regurgitation (acute vs chronic) 0.67 0.34-1.32
Patients entered in 1988 or later
Complication free survival Valve procedure (repair vs replacement) 0.61 0.32-1.16
Previous cardiac surgery (yes vs no) 2.27 1.14-4.54
Diabetes (yes vs no) 2.23 1.23-4.04
Survival Valve procedure (repair vs replacement) 0.45 0.22-0.93
Emergency operation (yes vs no) 2.12 1.06-4.24
Mitral regurgitation (acute vs. chronic) 0.19 (0.06, 0.64)
TABLE 9. Cox proportional hazards models for repair and replacement groups separately
Treatments Event Covariates Hazard ratio 95% CI
All patients
Repair (n = 151) Any complication or death NYHA functional class (IV vs ≤III) 3.205 1.57-6.54
Any death NYHA functional class (IV vs ≤III) 2.81 1.37-5.75
Replacement (n = 70) Any complication or death Structural failure (yes vs no) 0.325 0.14-0.75
Congestive heart failure (yes vs no) 2.88 0.39-21.26*
Any death Structural failure (yes vs no) 0.41 0.168-1.007*
Patients entered in 1988 or later
Repair (n = 125) Any complication or death NYHA functional class (IV vs ≤III) 3.49 1.31-9.32
Mitral regurgitation (acute vs chronic) 0.2 0.05-0.87
Emergency operation (yes vs no) 2.25 1.06-4.76
Any death NYHA functional class (IV vs ≤III) 4.16 1.57-11.03
Previous cardiac surgery (yes vs no) 3.82 1.64-8.89
Replacement (n = 33) Any complication or death Structure failure (yes vs no) 0.206 0.05-0.89
Gender (male vs female) 2.49 0.69-9.02*
Any death Structure failure (yes vs no) 0.343 0.09-1.33*
Gender (male vs female) 2.63 0.68-10.26*
*Included in best model from model selection process. Results from refitted model are shown.
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or papillary muscle) need to be readily discerned, but subtle,
ongoing pathologic processes of the subvalvular apparatus
must also be accurately appraised. The few patients with
valve reconstruction who required reoperation did so within a
short period after the original operation. These reoperations
were mainly because of further disruption of the subvalvular
apparatus when the extent of damage to the subvalvular appa-
ratus had not been fully appreciated initially. Although there
was a trend toward further reintervention in the patients with
valve repair, this difference can be attributed mainly to the
learning curve associated with recognizing the extent of
reconstruction in acute infarction. It is important to note that
in our series there were no late valve-related deaths among
patients undergoing further mitral valve surgery.
What Are the Long-term Benefits?
The 5-year survival among the patients with mitral recon-
struction in this series compares favorably with those reported
by others,5,6,13 which have ranged from approximately 64%
to 75%. Strikingly, the various subsets of patients undergoing
valve reconstruction had similar survivals regardless of the
pathophysiologic mechanism of the regurgitation. The overall
results are in sharp contrast to the study by Cohn and coin-
vestigators,6 which reported a 5-fold greater mortality among
patients with ischemic mitral regurgitation undergoing valve
reconstruction (56% freedom from death for repairs at 5 years
compared with 91% for replacement). Cohn and coinvestiga-
tors6 suggested that it was not the mitral reconstruction itself
that jeopardized patient survival; rather, annular dilation was
a surrogate variable for the poor ventricular function that
decreased late survival (5-year survival for reconstruction of
annular dilation 43%). Cosgrove similarly reported a 3-year
survival of only 48% among the patients who underwent
mitral reconstruction for ischemic annular dilation. In con-
trast, in this study patients undergoing valve reconstruction
for annular dilation had a 5-year survival of 71% (95% CI
61%-82%; Appendix Table 4).
Our experience with valve reconstruction for ischemic
insufficiency included both simple suture annuloplasty and ring
annuloplasty. Czer and coworkers2 reported less postoperative
mitral insufficiency after ring annuloplasty than after suture
annuloplasty for patients with pure annular dilation. In this
study both improved survival and improved complication-free
survival were associated with remodeling ring annuloplasty.
This report provides additional evidence that the well-
described benefits of valve reconstruction, such as superior
freedom from the valve-related complications of embolism
and endocarditis and from anticoagulant-related complica-
tions, also apply to patients with ischemic disease.
Limitations of the Study
The term ischemic mitral insufficiency includes multiple
pathologic disease processes with the final result of mitral
insufficiency. Our analysis, which began before the avail-
ability of routine echocardiography, used a classification
system similar to that proposed by Rankin and colleagues7
in the 1980s. Recently, with the advent of transesophageal
echocardiography and detailed leaflet analysis, a more func-
tional analysis has been developed with subgrouping of
either structural insufficiency or functional insufficiency.
Structural insufficiency includes those patients with rup-
tured or elongated chordae or papillary muscle defects (type
2). Functional insufficiency includes those patients with
restricted leaflet motion (type 3b) and those with annular
dilation (type 1). The classification system that we used can
be roughly translated into structural and functional cate-
gories. As more detailed studies of patients with ischemic
mitral insufficiency are performed, the functional analysis
will become the standard.
This patient series encompassed a 2-decade surgical
experience. This was a retrospective study without random-
ization, and the relatively small numbers in each group of
patients with this fairly rare disease made case matching
impractical. When the assignment of patients to treatments
is not random but is the result of some selection process that
may be biased, the attribution of causality becomes difficult.
In our series the choice of type of surgery was related to
characteristics of the patient at presentation as well as to
other unknown selection biases on the part of the surgeons.
In addition, in our series the 20-year span encompassed
changing technology and surgical techniques. Although
cold blood cardioplegia was used throughout the series, the
most significant change in our surgical practice occurred in
the middle portion of this experience with the introduction
of retrograde cardioplegia. The improved distribution of
cardioplegia with this method allowed us to more aggres-
sively pursue mitral reconstruction after this point in time,
thus changing surgical practice. In addition, the repair oper-
ation was infrequent before 1988. Our focus on patients
with surgery in 1988 or later allowed us to minimize the
effects of these changes on our results.
Conclusions
These analyses suggest that the type of surgery has little
influence on prognosis after adjustment for NYHA func-
tional class and presence of angina at time of surgery. After
exclusion of these two confounding variables, the risk of
death and the risk of complication or death within 30 days
of surgery were markedly reduced for patients who under-
went repair relative to patients who underwent replacement.
Similar results were obtained for total mortality and risk of
complication or death. When we examined the repair group
separately, the risk for death or complication was 3 times
greater for patients in NYHA functional class IV at surgery
than for those who were NYHA functional classes I through
III. From the models developed for each cohort separately,
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we have discerned the factors associated with increased
risks for patients selected for repair and for patients selected
for replacement that can provide guidance to the surgeon
with respect to selection of patients for these procedures.
We make the following recommendations. Aside from
catastrophic, acute structural mitral valve failure, mitral
valve reconstructive techniques are applicable in cases of
both acute and chronic ischemic mitral insufficiency. Those
patients with leaflet prolapse related to limited rupture of
chordae or papillary muscle tips should undergo repair with
the appropriate technique. Caution should be applied in the
case of patients with acute insufficiency related to ischemic
or infarcted papillary muscles; rather than relying on jeopar-
dized tissue for reconstruction, mitral replacement should be
performed in these cases. Likewise, patients with severe ven-
tricular-papillary dysfunction often have more reliable cor-
rection with valve replacement. Finally, patients with chronic
annular dilation have excellent results with mitral valve
reconstruction and ring annuloplasty. For these patients valve
repair provides superior freedom from valve-related compli-
cations with equivalent survival and therefore is preferred. In
summary, in the case of ischemic mitral valve disease, it is
up to the operating surgeon to appropriately choose valve
repair or replacement, depending on the acuity of the pre-
sentation and the pathophysiologic mechanism involved.
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Appendix TABLE 1. Survivals and complication-free survivals for all patients
Replacement Repair
Years No. at risk Survival 95% CI No. at risk Survival 95% CI
Survival
1 70 0.7 0.59-0.81 151 0.76 0.69-0.84
2 43 0.68 0.56-0.79 82 0.72 0.64-0.80
3 33 0.63 0.51-0.75 55 0.71 0.62-0.79
4 24 0.6 0.47-0.73 43 0.71 0.62-0.79
5 21 0.57 0.44-0.70 29 0.68 0.58-0.77
Complication-free survival
1 70 0.62 0.50-0.74 151 0.76 0.68-0.83
2 39 0.55 0.43-0.67 81 0.7 0.62-0.78
3 26 0.5 0.37-0.63 54 0.67 0.58-0.76
4 18 0.47 0.33-0.60 41 0.67 0.58-0.76
5 15 0.47 0.33-0.60 28 0.64 0.54-0.74
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Appendix TABLE 3. Cox models for late cardiac survival and for complication-free survival (for repair group only)
Event Covariates Hazard ratio 95% CI
Complication-free survival NYHA functional class (IV vs ≤III) 3.72 1.08-12.78
Previous cardiac surgery (yes vs no) 3.57 1.01-12.61
Ring annuloplasty vs suture annuloplasty 0.287 0.1-0.83
Death NYHA functional class (IV vs ≤III) 3.56 1.01-12.5
Previous cardiac surgery (yes vs no) 3.88 1.06-14.15
Ring annuloplasty vs suture annuloplasty 0.26 0.09-0.78
Appendix TABLE 4. Survivals and complication-free
survivals of patients in repair group entered in 1988
or after with isolated annular dilation
Years No. at risk Survival 95% CI
Survival
1 90 0.75 0.65-0.85
2 47 0.71 0.61-0.82
3 28 0.71 0.61-0.82
4 20 0.71 0.61-0.82
5 13 0.71 0.61-0.82
Complication-free survival
1 90 0.74 0.64-0.83
2 46 0.7 0.59-0.80
3 28 0.7 0.59-0.80
4 20 0.7 0.59-0.80
5 13 0.7 0.59-0.80
Appendix TABLE 2. Survivals and complication-free survivals for patients entered in 1988 or later
Replacement Repair
Years No. at risk Survival 95% CI No. at risk Survival 95% CI
Survival
1 33 0.7 0.53-0.86 127 0.77 0.69-0.84
2 19 0.65 0.47-0.83 66 0.74 0.66-0.82
3 11 0.65 0.50-0.83 41 0.72 0.63-0.81
4 6 0.51 0.22-0.79 30 0.72 0.62-0.81
5 4 0.34 0.01-0.66 17 0.71 0.62-0.81
Complication-free survival
1 33 0.63 0.46-0.81 127 0.76 0.68-0.84
2 17 0.58 0.40-0.76 65 0.73 0.65-0.81
3 9 0.49 0.25-0.71 41 0.71 0.62-0.80
4 4 0.29 0.00-0.61 30 0.71 0.62-0.80
5 2 0.29 0.00-0.61 17 0.71 0.62- 0.80
